Effect of short-term medroxyprogesterone acetate on left ventricular mass: Role of insulin-like growth factor-1

Metabolism: Clinical and Experimental

Volumn 48, Issue 10, 1999, Pages 1328-1331

  Sites, Cynthia K ^a   Tischler, Marc D ^b   Rosen, Clifford J ^b   O'Connell, Maureen ^b   Niggel, Joelyn ^b   Ashikaga, Takamaru ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE ACETATE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE MASS; HORMONE SUBSTITUTION; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0032743516     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90276-7     Document Type: Article

References (20)

1. Sites CK, Tischler MD, Blackman JA, et al: Effect of short-term hormone replacement therapy on left ventricular mass and contractile function. Fertil Steril 71:137-143, 1999
2. Dall'Aglio E, Valenti G, Hoffman AR, et al: Lack of effect of transdermal estrogen on the growth hormone-insulin-like growth factor axis. Horm Metab Res 26:211-212, 1994
3. Zofkova I, Kancheva RL: Effect of estrogen status on bone regulating hormones. Bone 19:227-232, 1996
4. Sato F, Ouchi Y, Masuyama A, et al: Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomizedrats. Calcif Tissue Int 53:111-116, 1993
5. Weissberger AJ, Ho KK, Lazarus L: Contrasting effects of estrogen replacement on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab 72:374-381, 1991
6. Shewmon DA, Stock JL, Rosen CJ, et al: Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women. Arterioscler Thromb 14:1586-1593, 1994
7. Helle SI, Omsjo IH, Hughes SC, et al: Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: A cross-over study. Clin Endocrinol (Oxf) 45:727-732, 1996
8. Goodman-Gruen D, Barrett-Connor E: Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo Study. J Clin Endocrinol Metab 81:4268-4271, 1996
9. Bellantoni MF, Harman SM, Cho DE, et al: Effects of progestinopposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J Clin Endocrinol Metab 72:172-178, 1991
10. Hartmann B, Kirchengast S, Albrecht A, et al: Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal women. Maturitas 22:239-246, 1995
11. Slowinska-Srzednicka J, Zgliczynski S, Jeske W, et al: Transdermal 17 beta-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest 15:533-538, 1992
12. Silverman BL, Friedlander JR: Is growth hormone good for the heart? J Pediatr 131:S70-S74, 1997 (suppl)
13. Fleiss JL: The Design and Analysis of Clinical Experiments. New York, NY, Wiley, 1986, pp 8-12
14. Breier BH, Gallaher BW, Gluckman PD: Insulin-like growth factor-I: Solutions to some potential problems and pitfalls. J Endocrinol 128:347-357, 1991
15. Cittadini A, Grossman JD, Napoli R, et al: Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29:1109-1116, 1997
16. Donath MY, Gosteli-Peter MA, Hauri C, et al: Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur J Endocrinol 137:309-315, 1997
17. Selman PJ, Mol JA, Rutteman GR, et al: Progestin treatment in the dog. I. Effects on growth hormone, insulin-like growth factor I and glucose homeostasis. Eur J Endocrinol 131:413-421, 1994
18. Mol JA, van Garderen E, Rutteman GR, et al: New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. J Steroid Biochem Mol Biol 57:67-71, 1996
19. Rajaram S, Baylink DJ, Mohan S: Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions. Endocr Rev 18:801-831, 1997
20. Snabes MC, Payne JP, Kopelen HA, et al: Physiologic estradiol replacement therapy and cardiac structure and function in normal postmenopausal women: A randomized, double-blind, placebocontrolled, crossover trial. Obstet Gynecol 89:332-339, 1997